Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.33 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.33 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20346367 | 0.84 | NAPRT (0.44) | L3MBTL1MAPTKDM4ECYP1A2HDAC4 | |
| SCHEMBL3113809 | 0.82 | CASP3 (0.41) | L3MBTL1MAPTKDM4ECYP1A2MEN1 | |
| SCHEMBL13496176 | 0.80 | CYP4F2 (0.45) | ALDH1A1L3MBTL1CYP1A2HDAC4HDAC6 | |
| SCHEMBL4061267 | 0.79 | MAPT (0.52) | ALDH1A1L3MBTL1MAPTKDM4EHSD17B10 | |
| SCHEMBL18304643 | 0.78 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1MAPTKDM4ECYP1A2 | |
| SCHEMBL18505712 | 0.76 | HDAC4 (0.37) | ALDH1A1KDM4EHSD17B10KMT2AHDAC4 | |
| SCHEMBL27723924 | 0.74 | L3MBTL1 (0.52) | ALDH1A1L3MBTL1MAPTKDM4ECYP1A2 | |
| SCHEMBL5115647 | 0.73 | L3MBTL1 (0.55) | ALDH1A1L3MBTL1MAPTKDM4ECYP1A2 | |
| SCHEMBL706704 | 0.73 | CTBP2 (0.46) | ALDH1A1MAPTKDM4ECYP1A2MEN1 | |
| SCHEMBL20955519 | 0.72 | CYP1A2 (0.51) | ALDH1A1L3MBTL1CYP1A2HSD17B10MAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329377-B2 | Imide compound and chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | IGF1R, CCNA1, MYC | ALDH1A1 386/4885L3MBTL1 3772/4885MAPT 3812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.